Data is presented by grouping rodent studies on palatable food intake, drugs of abuse, and studies on humans focusing on GLP-1 and reward systems
Structure 29 , 9891002.e6 (2021)
Market Segmentation Indication Insights (Revenue, USD Bn, 2021 - 2033) Chronic Weight Management Obstructive Sleep Apnea (OSA) Dosage Form Insights (Revenue, USD Bn, 2021 - 2033) Single-dose Pen Single-dose Vial Strength Insights (Revenue, USD Bn, 2021 - 2033) 5 mg 5 mg 5 mg 10 mg 5 mg 15 mg Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) Hospital Pharmacies Retail Pharmacies Online Pharmacies End User Insights (Revenue, USD Bn, 2021 - 2033) Hospitals Specialty Clinics Outpatient and Primary Care Centers Long-Term Care Facilities Others (Research and Academic Institutions, etc.) Regional Insights (Revenue, USD Bn, 2021 - 2033) North America U.S
10.3174/ajnr.A4431 301
It is not intended as medical advice for individual conditions or treatments